- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 6, 2026 | 212.02M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 226.11M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 224.57M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $59.81M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $11.91M |
| Capex | Q1 2026 · Mar 31, 2026 | $1.28M |
| Capex | Q1 2026 · Mar 31, 2025 | $1.51M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $24.26M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $495K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $444.14M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $481.06M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $260.26M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $273.69M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $295.38M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $310.48M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $562.25M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $625.31M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $734.19M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $789.18M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.07 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.07 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.02 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $13.76M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $12.69M |
| Net Income | Q1 2026 · Mar 31, 2026 | $15.25M |
| Net Income | Q1 2026 · Mar 31, 2025 | $3.44M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $12.73M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $3.29M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $85.37M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $69.17M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $31.87M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $23.9M |
| Revenue | Q1 2026 · Mar 31, 2026 | $117.24M |
| Revenue | Q1 2026 · Mar 31, 2025 | $93.06M |